Exosome-mediated transfer of lncRNA PART1 induces gefitinib resistance in esophageal squamous cell carcinoma via functioning as a competing endogenous RNA.
CONCLUSIONS: LncRNA PART1 promotes gefitinib resistance by regulating miR-129/Bcl-2 pathway, and may serve as a therapeutic target for ESCC patients.
PMID: 30049286 [PubMed - in process]
Source: Clinical Prostate Cancer - Category: Cancer & Oncology Authors: Kang M, Ren M, Li Y, Fu Y, Deng M, Li C Tags: J Exp Clin Cancer Res Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Esophagus Cancer | Fish | Prostate Cancer | Skin Cancer | Squamous Cell Carcinoma